Pharmacist's Letter | CE & Recommendations You Can Trust

Current Issue

April 2025 Issue

Be Ready if a Measles Outbreak Hits Your Community

Recent headlines will spur questions about managing measles...

Resources

Algorithm: Vaccine Adherence: Addressing Myths and Hesitancy
FAQ: Vaccinating Immunocompromised Patients

Nip Allergic Rhinitis in the Bud

Spring is here...

Watch for Tirzepatide for Sleep Apnea

Tirzepatide (Zepbound) will be the first Rx med approved to treat moderate to severe obstructive sleep apnea (OSA) in adults...

Minimize Multiple Anticholinergics in Older Patients

You’ll see renewed focus on limiting anticholinergic medications in older adults...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Type 2 Diabetes Patient Counseling

CE IN THE LETTER: Pharmacist's Letter April 2025

LIVE CE: Pharmacy Essential Updates April 2025

PODCAST CE: Medication Talk - Cardiovascular Impact of Diabetes Meds

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GO TO ALL CLINICAL RESOURCES >

What is Pharmacist’s Letter?

Pharmacist's Letter is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Free CE for Pharmacists

Pharmacist's Letter offers ACPE-accredited CE at no charge to help pharmacists meet license renewal requirements. Claim your free CE now:

Group Purchases & Pricing

Pharmacist’s Letter is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information